Ross S. Berkowitz

发表

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

R. Bast, T. Klug, E. S. ST JOHN, 1983, The New England journal of medicine.

Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.

R. Berkowitz, S. Mok, W. Welch, 1995, Oncogene.

Frequent microsatellite instability in epithelial borderline ovarian tumors.

R. Berkowitz, S. Mok, W. Welch, 1996, Cancer research.

Characterisation of human kallikrein 6/protease M expression in ovarian cancer

S. Mok, S. Ng, S. Ng, 2004, British Journal of Cancer.

Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

R. Berkowitz, S. Mok, W. Welch, 1998, Journal of the National Cancer Institute.

R. Berkowitz, S. Mok, W. Welch, 2000, Cancer research.

Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs).

R. Berkowitz, R. Knapp, J. Fletcher, 1995, Experimental cell research.

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.

W. Wong, R. Berkowitz, J. Barrett, 2009, Cancer cell.

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.

R. Berkowitz, S. Skates, D. Cramer, 2001, Journal of the National Cancer Institute.

Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors.

R. Berkowitz, S. Mok, D. Bell, 2001, Cancer research.

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

R. Berkowitz, S. Mok, W. Welch, 2000, The American journal of pathology.

SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

R. Berkowitz, S. Mok, K. Wong, 1996, Oncogene.

Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

R. Berkowitz, R. Knapp, S. Mok, 1994, Gynecologic oncology.

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

R. Berkowitz, A. Muzikansky, U. Matulonis, 2001, Gynecologic oncology.

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.

J. Niloff, R. Berkowitz, J. Garber, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

p53 gene mutation in human borderline epithelial ovarian tumors.

R. Berkowitz, S. Mok, W. Welch, 1994, Journal of the National Cancer Institute.

A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.

R. Berkowitz, S. Mok, W. Welch, 1997, Cancer research.

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.

R. Berkowitz, S. Mok, W. Welch, 1995, Cancer research.

Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.

R. Berkowitz, S. Mok, W. Welch, 2000, Gynecologic oncology.

Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.

R. Bast, R. Berkowitz, C. Griffiths, 1983, Cancer research.

Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.

R. Berkowitz, S. Mok, W. Welch, 2000, American journal of clinical pathology.

Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro.

R. Berkowitz, D. Anderson, C. Kurtz, 1988, American journal of obstetrics and gynecology.

Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.

R. Berkowitz, D. Goldstein, M. Bernstein, 1984, Gynecologic oncology.

Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center.

R. Berkowitz, C. Feltmate, D. Genest, 2001, Gynecologic oncology.

Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion

R. Berkowitz, J. Christensen, R. Salgia, 2007, International Journal of Gynecologic Cancer.

Frequent microsatellite instability in epithelial borderline ovarian tumors.

S. Mok, W. Welch, M. Muto, 1996, Cancer research.

Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors.

R. Berkowitz, S. Mok, W. Welch, 1995, Cancer research.

p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.

R. Berkowitz, S. Mok, D. Genest, 1998, The Journal of reproductive medicine.

Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.

R. Berkowitz, S. Mok, M. Muto, 2001, Cancer research.

Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center.

R. Berkowitz, B. Quade, C. Crum, 2015, Gynecologic oncology.

c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.

R. Berkowitz, S. Mok, D. Genest, 1998, The Journal of reproductive medicine.

Dysregulation of microRNA‐204 mediates migration and invasion of endometrial cancer by regulating FOXC1

R. Berkowitz, S. Mok, J. Kwong, 2012, International journal of cancer.